Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: The OFELY prospective study

Journal of Bone and Mineral Research

Volumn 17, Issue 5, 2002, Pages 826-833

  Garnero, Patrick ^a,b   Cloos, Paul ^c   Sornay Rendu, E ^a   Qvist, Per ^c   Delmas, Pierre D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Synarc   (France)

^c NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

Fracture risk; Isomerization; Osteoporosis; Racemization; Type I collagen

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CALCIUM INTAKE; CLINICAL TRIAL; CROSS LINKING; FEMALE; FEMUR NECK; FRACTURE; HUMAN; HUMAN EXPERIMENT; ISOMERISM; LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; PHYSICAL ACTIVITY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN PROCESSING; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE AND BONES; BONE DENSITY; COHORT STUDIES; COLLAGEN; COLLAGEN TYPE I; FEMALE; FRACTURES, BONE; FRANCE; HUMANS; ISOMERISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; RISK FACTORS; STEREOISOMERISM;

EID: 0036233579     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.5.826     Document Type: Article

References (28)

1. Collagen and bone strength
2. Compositional analysis of the collagenous bone matrix - A study on adult normal and osteopenic bone tissue
3. Alteration in the extent of collagen I hydroxylation, isolated from femoral heads of women with a femoral neck fracture caused by osteoporosis
4. Reduced concentration of collagen reducible cross-links in human trabecular bone with respect to age and osteoporosis
5. Characterization of urinary degradation products derived from type I collagen
6. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: A biological clock of protein aging with clinical potential
7. Decreased β isomerization of C-telopeptides of type I collagen in Paget's disease of bone
8. The relationships between the degree of β-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis fractures
9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
10. Apparent pre and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The OFELY cohort
11. Assessing vertebral fractures: A report by the National Osteoporosis Working Group on Vertebral Fractures
12. Defining incident vertebral deformity: A prospective comparison of several approaches
13. Immunoassay for quantifying type I collagen degradation products in urine evaluated
14. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
15. Risk factor for hip fracture derived from relative risks: An analysis applied to the population of Sweden
16. Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam Study
17. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study
18. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY Study
19. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study
20. The relative contribution of collagen fiber orientation, porosity, density, and mineralisation on bone strength
21. Osteoporosis and familial idiopathic scoliosis: Association with an abnormal alpha 2 (I) collagen
22. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for a glycine at the triple helix position 43 in the pro alpha 1 (I) chain of type I collagen
23. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density
24. Bone density in osteogenesis imperfecta may well be normal
25. Dipoles of the α-helix and β-sheet, their role in protein folding
26. Structural alterations in the peptide backbone β-amyloid core protein may account for its deposition and stability in Alzheimer disease
27. Racemization of Asp23 residue affects the aggregation of Alzheimer amyloid beta protein analogues